3D Printed Tablets Topped with Braille & Moon Patterns Help…

Comparison: Braille vs Moon Writing Systems for Medication

Feature	Braille System	Moon System
Origin	Developed by Louis Braille (1824)	Created by William Moon (1845)
Structure	Dot-based patterns using 6-position cells	Raised shapes based on Latin Roman letters
Learning Curve	Requires specialized training	Easier for those familiar with Roman alphabet
Tactile Recognition	Universal tactile writing system	More intuitive for late-blind individuals
Space Efficiency	Very compact	Requires more surface area
3D Print Compatibility	Excellent with SLS	Excellent with SLS
Weight Impact on Tablet	+3.8% per dot	+4.9% per pattern
Global Adoption	Widely used internationally	Less common, primarily in UK/English-speaking regions
Ideal For	Patients trained in Braille	Elderly patients losing vision later in life

Comparison: Traditional Tablets vs 3D Printed Printlets

Aspect	Traditional Tablets	3D Printed Printlets
Personalization	Mass-produced, fixed dosages	Patient-specific, customizable dosages
Identification	Visual labels only	Tactile patterns (Braille/Moon)
Accessibility	Difficult for visually impaired	Independent identification possible
Water Requirement	Usually required	Disintegrates orally (~5 seconds)
Shape Options	Limited (round, oval, capsule)	Unlimited geometrical possibilities
Drug Release	Standard formulations	Controlled release options available
Multi-Drug Capability	Multiple pills needed	Single printlet can contain multiple drugs
Manufacturing	Large batch processing	On-demand, small-batch production
Cost Per Unit	Lower at high volume	Higher but offset by personalization benefits
Medication Errors	Higher risk for visually impaired	Significantly reduced through tactile coding

Researchers from the UK and Spain continue to study the potential to use 3D printing to transform pharmaceuticals, outlining their studies in the recently published 3D Printed Tablets (Printlets) with Braille and Moon Patterns for Visually Impaired Patients.

3D printed medication is an ongoing focus for scientists and manufacturers today, eager to put all the benefits of progressive technology to use. And while the use of Braille with printlets is a novel idea, it fits in perfectly with the idea of patient-specific treatment—meant to prevent dosage errors and encourage the visually impaired to keep up with their medication.

Stating that data shows there are around 285 visually impaired individuals worldwide, the researchers offer their motivation for helping the blind, most of whom are over 50 and relying on medication.

“Previous studies revealed that one of the leading causes of medication non-adherence was impaired vision, wherein approximately 97% of patients with visual impairment have difficulties reading medication labels, even in the presence of optical aids, and around 24% have difficulties in distinguishing medications,” stated the researchers. “Moreover, patients with visual impairment are twice more likely to need assistance with medicine management, wherein one-third of the patients will require continual support for medication administration.”

While Braille is ‘the universal tactile writing system,’ the Moon system stems from Latin Roman letters produced using raised shapes—much like the regular alphabet in structure. The researchers decided to print these writing systems directly onto the printlets.

SLS 3D Printing Technology

Selective Laser Sintering (SLS) 3D printing is the key technology behind these innovative printlets. Unlike traditional manufacturing methods that compress powder into tablets using molds, SLS uses a laser to selectively fuse pharmaceutical powder layer by layer. This process creates complex three-dimensional structures with precise control over geometry and composition.

The SLS process works by spreading a thin layer of pharmaceutical powder across a build platform. A laser then scans the cross-section of the desired tablet design, fusing the powder particles together. The platform lowers, a new layer of powder is spread, and the process repeats. This layer-by-layer approach allows for the creation of intricate surface patterns like Braille dots and Moon characters.

For the Braille and Moon pattern printlets, researchers used paracetamol as the model drug. The SLS process successfully created orally disintegrating printlets (ODPs) that could quickly dissolve in the mouth without water—a crucial feature for patients with visual impairments who may struggle with pill-swallowing coordination.

Advantages for Visually Impaired Patients

The integration of Braille and Moon patterns directly onto tablet surfaces addresses several critical challenges faced by visually impaired individuals:

• Independence: Patients can identify their medications without assistance from caregivers or family members.
• Error Prevention: Tactile identification reduces the risk of taking the wrong medication or incorrect dosage.
• Faster Disintegration: The printlets dissolve within approximately 5 seconds, eliminating the need for water and making administration easier.
• Improved Adherence: When patients can independently manage their medications, they’re more likely to follow treatment regimens consistently.

The Impact of Visual Impairment on Medication Adherence

Visual impairment presents significant challenges for medication management. According to global statistics, approximately 285 million people worldwide live with visual impairment, with the majority being over age 50 and reliant on daily medications.

Research reveals that vision problems are one of the leading causes of medication non-adherence. Key statistics highlight the severity of this issue:

• 97% of visually impaired patients have difficulty reading medication labels, even when using optical aids like magnifying glasses.
• 24% struggle to distinguish between different medications based on packaging or pill appearance alone.
• 2x more likely to need assistance with medicine management compared to sighted individuals.
• 33% require continual support for medication administration.

These statistics underscore why innovative solutions like tactile-coded printlets are so necessary. Traditional reliance on visual labels and packaging creates barriers to independence and increases the risk of potentially dangerous medication errors.

Braille vs Moon: Understanding the Difference

While Braille is recognized as “the universal tactile writing system,” the Moon system offers an alternative approach that may be more accessible for certain patient populations.

Braille uses a system of six raised dots arranged in different combinations to represent letters, numbers, and punctuation. This dot-based system is highly space-efficient and widely used internationally. However, learning Braille requires specialized training, and it can be challenging for individuals who lose their vision later in life.

Moon uses raised shapes that closely mirror the forms of Latin Roman letters. This makes Moon more intuitive for patients who learned to read using the standard alphabet before losing their vision. The familiar letter shapes create a shorter learning curve for late-blind individuals, particularly elderly patients.

The research team wisely chose to incorporate both systems, recognizing that different patients will have different preferences and capabilities. By demonstrating that both systems can be successfully 3D printed onto tablets, the study opens the door for personalized medication labeling that matches each patient’s specific needs and background.

Technical Performance of Patterned Printlets

A critical question in developing these innovative printlets was whether adding tactile patterns would affect the tablet’s performance. The research team conducted comprehensive testing to ensure that Braille and Moon patterns wouldn’t compromise medication delivery.

Weight and Mechanical Properties

The study found that adding patterns does increase the weight of printlets, but the impact is minimal and manageable:

• One Braille dot adds a 3.8% weight increase
• Moon patterns add a 4.9% weight increase

Despite these weight increases, the mechanical properties of the printlets remained unaffected. See also: Best 3D Printer Upgrades That Actually Improve Pri…. The tablets maintained their structural integrity and function, confirming that the patterns don’t compromise the physical characteristics needed for proper drug delivery.

Disintegration and Drug Release

Perhaps most importantly, the disintegration properties and drug release rates were not significantly impacted by the surface patterns. This means that the printlets continue to dissolve quickly in the mouth (within about 5 seconds) and release medication as intended, regardless of whether they feature Braille dots, Moon patterns, or no patterns at all.

This performance consistency is crucial for pharmaceutical applications. Any variation in drug delivery could affect treatment efficacy and patient safety. The research confirms that the benefits of tactile coding can be achieved without sacrificing pharmacological performance.

Future Applications and Possibilities

The researchers involved in this study envision numerous future applications for 3D printed tactile-coded medications:

Shape Coding Beyond Letters

The potential extends beyond just spelling out drug names using Braille or Moon characters. Different tablet shapes could convey information about:

• Medication timing: Morning medications might have one shape, evening medications another
• Therapeutic category: Cardiovascular drugs, pain relievers, or antibiotics could each have distinctive shapes
• Dosage strength: Larger or smaller shapes could indicate different dose levels

This multi-dimensional coding system could create a comprehensive tactile language for medications, enabling patients to identify key characteristics through touch alone.

Multi-Drug Printlets

3D printing technology allows for the creation of single printlets containing multiple drugs with different release profiles. For patients taking several medications daily, this could mean fewer pills to manage and simplified dosing schedules. Combined with tactile coding, multi-drug printlets could significantly reduce complexity for visually impaired patients.

Personalized Dosing

One of the most promising aspects of 3D printed pharmaceuticals is the ability to create patient-specific dosages. Rather than manufacturing pills in standard strengths (5mg, 10mg, 20mg), 3D printing can produce exact dosages tailored to individual patient needs. This precision medicine approach, combined with tactile identification, could revolutionize treatment for visually impaired patients.

Cost Considerations and Accessibility

While 3D printed medications currently cost more to produce than mass-manufactured tablets, several factors may improve accessibility in the future:

Technology Advancement

As 3D printing technology matures and becomes more widely adopted in pharmaceutical manufacturing, costs are expected to decrease. The SLS printers and pharmaceutical-grade powders used in this research will likely become more affordable over time.

On-Demand Production

The ability to produce medications on-demand in pharmacies or hospitals could reduce inventory costs and waste. Rather than stocking multiple strengths and formulations, facilities could produce medications as needed, customized for each patient.

Reduced Healthcare Costs

Improved medication adherence and reduced medication errors could generate substantial healthcare cost savings. Preventing errors and ensuring patients take medications correctly reduces hospitalizations, complications, and additional treatments.

Regulatory and Safety Considerations

The introduction of 3D printed medications with tactile patterns raises important regulatory questions. Pharmaceutical regulatory agencies like the FDA and EMA will need to establish guidelines for:

• Quality control: Ensuring consistent print quality for tactile patterns
• Pattern verification: Confirming that the correct patterns are printed on each medication batch
• Standardization: Establishing industry standards for tactile medication coding systems

The researchers’ study provides valuable baseline data showing that these innovations don’t compromise pharmaceutical performance. As the technology moves closer to clinical application, regulatory frameworks will need to evolve alongside it.

The Broader Impact of 3D Printing on Pharmaceuticals

This research on Braille and Moon patterned printlets is part of a larger trend exploring how 3D printing can transform pharmaceuticals:

Accelerated Drug Delivery

3D printing enables the creation of complex internal structures that can control how quickly or slowly drugs are released. This precision could lead to more effective treatments with fewer side effects.

Multi-Drug Controlled Release

Single 3D printed pills can contain multiple medications with different release profiles, simplifying complex treatment regimens. A patient might take one pill instead of five, with each drug releasing at the optimal time.

Micro-Scale Printing

Advances in 3D printing technology enable the creation of microscopic drug delivery systems, opening new possibilities for targeted treatments and precise dosing.

These innovations collectively point toward a future of personalized, patient-centered pharmaceutical manufacturing that prioritizes individual needs over mass production efficiency.

“Favorably, this technology offers the added benefit of using different shapes that could be inferred to a medication’s name, timing of intake (e.g., morning/evening), or its targeted indication (e.g., cardiovascular drugs),” concluded the researchers. See also: Prusa Research Mini+ vs Prusa MK4: Full Specs Comp…. “More importantly, as the pattern is directly printed on top of the tablet, the medication could be easily identified even when taken out of the packaging. This decreases the risk of medication errors and improves adherence to treatment. In addition, as these printlets disintegrate rapidly (e.g., within ~5 s), they avoid the need for water. This makes it easier for these patients to swallow the formulations, supporting self-administration and thus avoiding the need of a career.”

“For the first time, this study demonstrates the use of 3D printing to fabricate personalized dosage forms targeted to blind or visually impaired individuals. The SLS 3D printing technique could be used to manufacture printlets with Braille or Moon patterns on their surface that could be read by blind individuals. It is likely that this innovative concept will provide a revolutionary approach for the treatment of visually impaired individuals, improving independence, medicine adherence and reducing medicine errors.”

Conclusion

The development of 3D printed tablets with Braille and Moon patterns represents a significant step forward in making pharmaceuticals more accessible to visually impaired patients. By combining SLS 3D printing technology with proven tactile writing systems, researchers have created a solution that addresses real-world challenges while maintaining pharmaceutical performance.

This innovation demonstrates how additive manufacturing can serve needs that traditional manufacturing methods cannot address. For the 285 million visually impaired individuals worldwide, particularly the 97% who struggle to read medication labels, tactile-coded printlets offer a path to greater independence, safety, and treatment adherence.

As 3D printing technology continues to advance and become more accessible, we can expect to see further innovations in personalized pharmaceuticals. The ability to create medications that are tailored not just to clinical needs but to patient capabilities and preferences represents a new paradigm in healthcare—one that puts patients at the center of treatment design.

For the visually impaired community, these developments offer hope for greater autonomy in managing their health. When a patient can independently identify and take their medication correctly, it’s not just a convenience—it’s a matter of dignity, safety, and quality of life.

Frequently Asked Questions

Sources and Further Reading

• 3D Printed Tablets (Printlets) with Braille and Moon Patterns for Visually Impaired Patients – Original research paper from Pharmaceutics journal (MDPI)
• FabRx Printlets – Pharmaceutical 3D printing research company specializing in personalized medicine
• World Health Organization Visual Impairment Data – Global statistics on visual impairment
• National Federation of the Blind – Resources on Braille literacy and independence for the visually impaired
• American Foundation for the Blind – Information on Moon code and alternative tactile systems